Drugs Made In America Acquisition II Corp.
Last updated September 27, 2026
Organization details
- Legal name
- Drugs Made In America Acquisition II Corp.
- Ownership
- Public
- Status
- Active
- SIC code
- 6770 — Blank Checks
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DMII
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002040475
Board of directors
-
Catherine Do · DirectorSince 2025
-
Lynn Stockwell · Director · CEO and Exe. Chair of BoardSince 2025
-
Myron W. Shulgan · DirectorSince 2025
-
Sridhar G. Prasad · DirectorSince 2025
Chief executives
Lynn Stockwell
· CEO & Exe. Chair of the Board
Since September 2025
Board connections
4 of this board's directors also sit on 1 other board.
- via Catherine Do, Lynn Stockwell, Myron W. Shulgan and Sridhar G. Prasad
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 26, 2025 | Catherine Do Director | Other | +100,000 | — | — |
| Sep 26, 2025 | Myron W. Shulgan Director | Other | +100,000 | — | — |
| Sep 26, 2025 | Worman Glenn C. Officer (CFO) | Other | +100,000 | — | — |
| Sep 26, 2025 | Lynn Stockwell Director, Officer (CEO and Exe. Chair of Board), 10% owner | Open-market purchase | +700,000 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC 10% owner | Open-market purchase | +700,000 | — | — |
| Sep 26, 2025 | Sridhar G. Prasad Director | Other | +100,000 | — | — |
| Sep 26, 2025 | Lynn Stockwell Director, Officer (CEO and Exe. Chair of Board), 10% owner | Other | −400,000 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC 10% owner | Other | −400,000 | — | — |
| Sep 26, 2025 | Lynn Stockwell Director, Officer (CEO and Exe. Chair of Board), 10% owner | Open-market sale | −7,966,667 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC 10% owner | Open-market sale | −7,966,667 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.